SPRINGDALE, Ark. — A Northwest Arkansas company has created a rapid COVID-19 antibody test that has approval by the European Union.
“It’s pretty amazing, I’m really proud of the team. We’ve got about 37 people here or so who are so focused and working 24/7 to get this test developed,” said Kevin Clark, Now Diagnostics CEO.
Interested in learning more? You can read the full article here.
NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit www.nowdx.com. For more information about the ADEXUSDx® COVID-19 Test, including its intended use, features, benefits and limitations, and directions for use, visit www.c19development.com. The ADEXUSDx® COVID-19 Test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories may contact www.c19development.com/order to place an order.
NOWDiagnostics Company Contact
Beth Cobb, Director of Operations
NOWDiagnostics Media Contact
Claire Burghoff, CGA Group